Boosting 'good cholesterol' won't keep heart disease at bay after all - OregonLive.com

OregonLive.com

Boosting 'good cholesterol' won't keep heart disease at bay after all OregonLive.com That result is expected to lead doctors who prescribe niacin or other medications aimed at aggressively raising HDL, or high-density lipoproteins, to reconsider how they treat patients whose levels are low. Plus, pharmaceutical companies developing ... NATURAL HEALTH: Cholesterol is misunderstoodNiagara Gazette "Good" Cholesterol Not So Good After All, New Study ShowsSingularity Hub LDL cholesterol isn't entirely badGainesville Sun Palm Beach Post all 19 news articles »

European expert presents new guidelines in cardio care - Philippine Star

European expert presents new guidelines in cardio care Philippine Star Dyslipidaemia is a spectrum of coronary afflictions that includes the condition of having high levels of bad cholesterol (low-density lipoprotein or LDL) and decreased amounts of good cholesterol (high-density lipoprotein or HDL) in the blood.

Raising HDL Levels May Not Lower Heart Attack Risk - WebMD

Forbes

Raising HDL Levels May Not Lower Heart Attack Risk WebMD Genetic studies failed to show a link between higher concentrations of high-density lipoprotein (HDL) cholesterol and lower heart attack risk. Millions of people take statin drugs like Crestor, Lipitor, Pravachol, and Zocor to lower their low-density ... Doubt Cast on the 'Good' in 'Good Cholesterol'New York Times Study questions whether raising “good" cholesterol reduces heart attack riskBoston.com Genetic study questions HDL levels and the risk of MITheHeart.Org Pittsburgh Post Gazette -Forbes all 146 news articles »

Extended-Release Niacin Blocks Postprandial HDL Reduction - Medscape

Extended-Release Niacin Blocks Postprandial HDL Reduction Medscape April 30, 2012 (Chicago, Illinois) — High-density-lipoprotein (HDL) cholesterol decreases significantly after an oral fat load. One-time dosing with either 1 or 2 g of extended-release (ER) niacin mitigated this decline in drug-naïve subjects.

Doctors Find Less Need For Abbott's 'Good Cholesterol' Pill - Forbes

Forbes

Doctors Find Less Need For Abbott's 'Good Cholesterol' Pill Forbes But the so-called AIM-HIGH study, which was eventually published in the New England Journal of Medicine in November of last year, concluded “there was no incremental benefit from the addition of niacin to statin therapy during a 36-month follow-up ... and more »